yea with some $$ in the bank, money back from bayerand some residuals from deals, etc., it's not the worst stock on the asx to have a speccie punt on
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential